Intracoastal Capital, Kopin Divest Entire Helius Medical Stake
Ticker: HSDT · Form: SC 13G/A · Filed: Feb 6, 2024 · CIK: 1610853
| Field | Detail |
|---|---|
| Company | Helius Medical Technologies, Inc. (HSDT) |
| Form Type | SC 13G/A |
| Filed Date | Feb 6, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: insider-sell, ownership-change, institutional-investor, divestment
TL;DR
**Major investor Intracoastal Capital and Mitchell Kopin sold all their Helius Medical shares.**
AI Summary
Intracoastal Capital, LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed an amended Schedule 13G/A on February 6, 2024, indicating a change in their beneficial ownership of Helius Medical Technologies, Inc. common stock as of December 31, 2023. The filing shows that Mitchell P. Kopin now beneficially owns 0 shares, a significant decrease from previous holdings, while Intracoastal Capital, LLC also reports 0 shares. This matters to investors because it signals that a notable institutional investor and its principals have completely divested their stake in Helius Medical Technologies, Inc., potentially indicating a loss of confidence or a strategic portfolio reallocation.
Why It Matters
This divestment by a significant investor could signal a lack of confidence in Helius Medical Technologies' future prospects, potentially leading to negative market sentiment and downward pressure on the stock price.
Risk Assessment
Risk Level: medium — The complete divestment by a reporting person could indicate underlying issues or a lack of future growth potential, posing a moderate risk to current and prospective investors.
Analyst Insight
A smart investor would consider this complete divestment by a significant holder as a potential red flag and conduct further due diligence into Helius Medical Technologies, Inc.'s recent performance and future outlook before making any investment decisions.
Key Numbers
- 0 — Shares beneficially owned by Mitchell P. Kopin (Indicates a complete divestment of his stake in Helius Medical Technologies, Inc. as of December 31, 2023.)
- 0 — Shares beneficially owned by Intracoastal Capital, LLC (Indicates a complete divestment of its stake in Helius Medical Technologies, Inc. as of December 31, 2023.)
- December 31, 2023 — Date of Event (The date on which the change in beneficial ownership occurred, triggering this filing.)
- February 6, 2024 — Filing Date (The date the SC 13G/A amendment was filed with the SEC.)
Key Players & Entities
- Intracoastal Capital, LLC (company) — reporting person, divested shares
- Mitchell P. Kopin (person) — reporting person, divested shares
- Daniel B. Asher (person) — group member, associated with reporting persons
- Helius Medical Technologies, Inc. (company) — subject company whose stock was sold
- 0 shares (dollar_amount) — beneficially owned by Mitchell P. Kopin as of Dec 31, 2023
Forward-Looking Statements
- Helius Medical Technologies, Inc. stock price may experience downward pressure. (Helius Medical Technologies, Inc.) — medium confidence, target: Q1 2024
- Other institutional investors may re-evaluate their positions in Helius Medical Technologies, Inc. (Institutional Investors) — low confidence, target: Q2 2024
FAQ
What is the primary purpose of this SC 13G/A filing by Intracoastal Capital, LLC and Mitchell P. Kopin?
The primary purpose of this SC 13G/A filing is to amend previous Schedule 13G filings, specifically Amendment No. 2, to report a change in beneficial ownership of Helius Medical Technologies, Inc. common stock as of December 31, 2023, indicating a complete divestment of their holdings.
How many shares of Helius Medical Technologies, Inc. common stock does Mitchell P. Kopin beneficially own as of the event date?
As of December 31, 2023, Mitchell P. Kopin beneficially owns 0 shares of Helius Medical Technologies, Inc. common stock, as stated on Page 1 of 6, CUSIP No. 42328V801.
What is the CUSIP number for Helius Medical Technologies, Inc. common stock mentioned in the filing?
The CUSIP number for Helius Medical Technologies, Inc. common stock is 42328V801, as indicated on Page 1 of 6 of the filing.
Which rule under the Securities Exchange Act of 1934 is designated for this Schedule 13G filing?
This Schedule 13G filing designates Rule 13d-1(c) under the Securities Exchange Act of 1934, as marked on the cover page of the filing.
Who are the group members associated with the reporting persons in this filing?
The group members associated with the reporting persons are Daniel B. Asher and Mitchell P. Kopin, as listed in the 'GROUP MEMBERS' section of the filing's header information.
Filing Stats: 1,026 words · 4 min read · ~3 pages · Grade level 7.7 · Accepted 2024-02-06 10:22:13
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class o
Filing Documents
- ea192883-13ga2intra_helius.htm (SC 13G/A) — 53KB
- 0001213900-24-010325.txt ( ) — 55KB
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following þ . Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11. Page 5 of 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 6, 2024 /s/ Mitchell P. Kopin Mitchell P. Kopin /s/ Daniel B. Asher Daniel B. Asher Intracoastal Capital LLC By: /s/ Mitchell P. Kopin Mitchell P. Kopin, Manager Page 6 of 6